ADORX THERAPEUTICS LIMITED
Company number SC558719 · Monitor this company
Free AI analysis
Have an AI read this company's filings and write an assessment — financial health, risks, and what the numbers say.
Shareholders' funds
£4,860,345
Balance sheet as at 2025-02-28
What it does
The principal activity of the company continued to be that of research and development of therapeutics for cancer and commercialising these therapies.
The company's own description, from its latest filed accounts.
Overview
- Company type
- Private Limited Company
- Incorporated
- 2017-02-24
- Employees
- 0 (2025 accounts)
- Registered office
- 137a George Street, Edinburgh, EH2 4JY
- Postcode
- EH2 4JY
- Capital
- 382 GBP
- Accounts category
- Full
Accounts
- Last made up to
- 2025-02-28
- Next due by
- 2026-11-30
- Financial year end
- 28 February
Confirmation statement
- Last statement dated
- 2026-02-24
- Next due by
- 2027-03-10
Nature of business (SIC)
- 72110 Research and experimental development on biotechnology
Officers 3 current · 1 resigned
Group structure
Controlled by CRT PIONEER GP LIMITED — since 2018-03-09
Controlled by EPIDAREX CAPITAL PARTNERS LIMITED — since 2017-02-24
From persons-with-significant-control filings on the public register.
Among its peers
Top 10%
by shareholders' funds, of 70 similar companies in EH
Trading since 2017.
No.5 of the largest research and experimental development on biotechnology companies in Edinburgh →
Competitors Edinburgh
This company ranks 5 among research and experimental development on biotechnology in Edinburgh.
The class of 2017
37%
of the 435 companies in this sector incorporated in 2017 are still active today; 61% have since been dissolved.
A fact about the year, not a forecast for this company.